Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis

被引：0
|
作者：
Huihui Jiang
Aiqun Xu
Wanli Xia
Xingyuan Xia
Pulin Li
Binbin Zhang
Ke Zhu
Sijing Zhou
Ran Wang
机构：
[1] The First Affiliated Hospital of Anhui Medical University,Department of Respiratory and Critical Care Medicine
[2] Hefei Second People’s Hospital,Department of General Medicine
[3] The First Affiliated Hospital of Anhui Medical University,Department of Thoracic Surgery
[4] Hefei Third Clinical College of Anhui Medical University,undefined
[5] Hefei Prevention and Treatment Center for Occupational Diseases,undefined
来源：
Cancer Cell International | / 21卷
关键词：
Antitumor drugs; Ipilimumab; Lung cancer; Nivolumab; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis
    Peng, Min
    Li, Xing
    Lei, Gu
    Weng, Yi Ming
    Hu, Meng Xue
    Song, Qi Bin
    ONCOTARGETS AND THERAPY, 2018, 11 : 7369 - 7383
  • [32] Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis
    Zhang, Hongman
    Shen, Jie
    Yi, Lilan
    Zhang, Wei
    Luo, Peng
    Zhang, Jian
    JOURNAL OF CANCER, 2018, 9 (23): : 4556 - 4567
  • [33] Meta-Analysis of Monotherapy Versus Combination Therapy for Pulmonary Arterial Hypertension
    Fox, Benjamin D.
    Shimony, Avi
    Langleben, David
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (08): : 1177 - 1182
  • [34] Nivolumab monotherapy and associations in the treatment of advanced unresectable biliary tract cancer (BTC): A systematic review and meta-analysis
    Filogonio, Victor
    Maia, Yara Rafaela
    Maia, Lucas Henrique
    Beck, Mauren Carbonar
    Beck, Theodoro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
    Lajoie, Annie Christine
    Lauziere, Gabriel
    Lega, Jean-Christophe
    Lacasse, Yves
    Martin, Sylvie
    Simard, Serge
    Bonnett, Sebastien
    Provencher, Steeve
    LANCET RESPIRATORY MEDICINE, 2016, 4 (04): : 291 - 305
  • [36] Model-Informed Immunogenicity Assessment of Nivolumab as Monotherapy and in Combination with Ipilimumab
    Yue Zhao
    Li Li
    Jessica Ma
    Amit Roy
    Akintunde Bello
    Jennifer Sheng
    Lora Hamuro
    The AAPS Journal, 27 (4)
  • [37] Efficacy and safety of nivolumab plus ipilimumab versus nivolumab alone in patients with advanced melanoma: a systematic review and meta-analysis
    Cui, Shuting
    Sun, Xiaozhe
    Gao, Junxi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (05) : 283 - 291
  • [38] Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038
    Ribas, Antoni
    Martin-Algarra, Salvador
    Bhatia, Shailender
    Hwu, Wen-Jen
    Slingluff, Craig L.
    Sharfman, William H.
    Hodi, F. Stephen
    Urba, Walter J.
    Luke, Jason J.
    Haanen, John B.
    Callahan, Margaret K.
    Wolchok, Jedd D.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Young, Tina C.
    Qureshi, Anila
    Horak, Christine E.
    CANCER RESEARCH, 2017, 77
  • [39] Combination Treatment with Iodine 125 Seeds Implant and Systemic Therapy vs. Systemic Therapy Alone for Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
    Li, Huzi
    Li, Wentao
    Zhang, Libo
    Fang, Wenyan
    Zhang, Hong
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (01): : 88 - 95
  • [40] Monotherapy vs combination therapy in patients with Klebsiella pneumoniae bloodstream infection: A systematic review and meta-analysis
    Li, Dan
    Rao, Huayun
    Xu, Yi
    Zhang, Min
    Zhang, Jie
    Luo, Jianrong
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (05) : 372 - 378
12345